A detailed history of International Biotechnology Trust PLC transactions in Insmed Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 40,100 shares of INSM stock, worth $2.97 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
40,100
Previous 40,100 -0.0%
Holding current value
$2.97 Million
Previous $846,000 19.62%
% of portfolio
0.34%
Previous 0.26%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$20.88 - $28.21 $820,771 - $1.11 Million
39,309 Added 4969.53%
40,100 $864,000
Q2 2022

Aug 16, 2022

SELL
$17.07 - $25.71 $671,004 - $1.01 Million
-39,309 Reduced 98.03%
791 $40.1 Million
Q1 2022

May 20, 2022

SELL
$20.42 - $28.13 $1.65 Million - $2.28 Million
-81,000 Reduced 66.89%
40,100 $942,000
Q4 2021

Feb 15, 2022

SELL
$25.89 - $33.45 $3.11 Million - $4.01 Million
-120,000 Reduced 49.77%
121,100 $3.3 Million
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $3.17 Million - $4.16 Million
141,000 Added 140.86%
241,100 $6.64 Million
Q2 2021

Aug 11, 2021

BUY
$24.17 - $36.01 $1.61 Million - $2.39 Million
66,500 Added 197.92%
100,100 $2.85 Million
Q4 2019

May 18, 2020

SELL
$16.12 - $24.98 $5.21 Million - $8.07 Million
-323,000 Reduced 90.58%
33,600 $801,000
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $5.67 Million - $7.94 Million
246,600 Added 224.18%
356,600 $9.11 Million
Q1 2019

May 14, 2019

BUY
$13.91 - $31.15 $1.53 Million - $3.43 Million
110,000 New
110,000 $3.2 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.